About PharMingen
PharMingen is a company based in San Diego (United States) founded in 1994 was acquired by Becton Dickinson in May 1997. The company has 653 employees as of September 30, 2024. PharMingen operates in a competitive market with competitors including Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others.
- Headquarter San Diego, United States
- Employees 653 as on 30 Sep, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
$164.71 M (USD)5as on Mar 31, 2024
-
Net Profit
$9.1 M (USD)24as on Mar 31, 2024
-
EBITDA
$17.4 M (USD)13as on Mar 31, 2024
-
Latest Funding Round
Not available
- Investors
-
Employee Count
653
as on Sep 30, 2024
-
Acquired by
Becton Dickinson
(May 19, 1997)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of PharMingen
Detailed funding history for PharMingen
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in PharMingen
PharMingen has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include BD.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
BD is recognized for providing innovative medical technology solutions.
|
Locked | Locked | Locked |
Investor details for PharMingen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PharMingen
Investment portfolio details for PharMingen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PharMingen
Detailed financials for PharMingen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pharmingen Comparisons
Peer comparison for PharMingen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PharMingen
PharMingen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Portfolio of products and services for life science research and clinical diagnostic markets
|
|
| Locked | Locked | Locked |
AI-based medical diagnostics are developed for healthcare applications.
|
|
| Locked | Locked | Locked |
Merck is engaged in science and technology solutions globally.
|
|
| Locked | Locked | Locked |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| Locked | Locked | Locked |
Primary antibodies and instruments for immunohistochemistry are manufactured.
|
|
| Locked | Locked | Locked |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
Detailed competitors of PharMingen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pharmingen
Complete news archive for PharMingen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PharMingen
PharMingen was founded in 1994.
PharMingen is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
As of Sep 30, 2024, the latest employee count at PharMingen is 653.
Annual revenue of PharMingen is $164.71M as on Mar 31, 2024.
PharMingen was founded in 1994 in San Diego, United States, focusing on the biotechnology sector for research tools. Operations involve the development, manufacturing, and distribution of monoclonal antibodies, their conjugates, polyclonal antibodies, protein expression systems, and recombinant proteins targeted at immunology, cell biology, and molecular biology applications. The company was acquired by Becton Dickinson Company in May 1997.
PharMingen's top competitors include Biocare Medical, Merck and Siemens Healthineers.
PharMingen has 1 investor. Key investors include BD.